NYSE:EW
Edwards Lifesciences Corporation Stock News
$89.78
+0.640 (+0.718%)
At Close: May 20, 2024
Long-Term Leaders List Welcomes This Giant Software Company
07:03pm, Friday, 07'th Aug 2020
IBD's Long-Term Leaders continue to power higher as the raging bull market hits new highs. Long-Term Leader Portfolio Welcomes Salesforce.com Led by founder Marc Benioff, Salesforce.com (CRM) remains
TMO vs. EW: Which Stock Is the Better Value Option?
03:40pm, Thursday, 06'th Aug 2020
TMO vs. EW: Which Stock Is the Better Value Option?
Edwards Lifesciences Shows Surprising Resilience, And TAVR Remains A Growth Market (NYSE:EW)
10:24am, Tuesday, 04'th Aug 2020
TAVR procedures were surprisingly resilient in the second quarter, driving a large revenue and profit beat for Edwards.
Vanguard Health Care Fund Adds 3 Stocks to Portfolio
04:58pm, Friday, 31'st Jul 2020
Fund focused on health reveals 2nd-quarter trades Continue reading...
Thermo Fisher Long Case: Trajectory Is Clear, Buy On Value
03:50pm, Friday, 31'st Jul 2020
Strong quarter exit and clear guidance for Q4 2020 on the back of $1.3 billion in COVID-19 related sales YTD.
The Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
07:18pm, Monday, 27'th Jul 2020
Health care-focused fund releases 2nd-quarter portfolio Continue reading...
Edwards Lifesciences (NYSE:EW) Price Target Raised to $89.00
09:47am, Monday, 27'th Jul 2020
Edwards Lifesciences (NYSE:EW) had its price target increased by Canaccord Genuity from $86.00 to $89.00 in a research report released on Friday, The Fly reports. The brokerage currently has a buy rat
Stifel Nicolaus Boosts Edwards Lifesciences (NYSE:EW) Price Target to $90.00
05:38am, Monday, 27'th Jul 2020
Edwards Lifesciences (NYSE:EW) had its target price raised by Stifel Nicolaus from $85.00 to $90.00 in a research report report published on Friday, BenzingaRatingsTable reports. Stifel Nicolaus curre
Edwards Inches Closer To Breakout On $100 Million Heart-Valve Beat
08:24pm, Friday, 24'th Jul 2020
Edwards Lifesciences handily topped Wall Street's second-quarter expectations amid a resurgence in heart-valve replacements. EW stock inched slightly closer to a buy point Friday.
P/E Ratio Insights for Edwards Lifesciences
01:48pm, Friday, 24'th Jul 2020
In the current session, Edwards Lifesciences Inc. (NYSE: EW) is trading at $77.38, after a 0.05% rise. Over the past month, the stock increased by 20.14%, and in the past year, by 11.87%. With perform
Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View
01:22pm, Friday, 24'th Jul 2020
Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.
Edwards Lifesciences Blows Past Q2 Earnings Estimates
10:03am, Friday, 24'th Jul 2020
Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thu
Edwards Lifesciences Corp (EW) Q2 2020 Earnings Call Transcript
02:31am, Friday, 24'th Jul 2020
With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer and Scott Ullem Chief Financial Officer. Just after the close of regular trading, Edwards Lifesciences released second
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Edwards Lifesciences' (EW) CEO Mike Mussallem on Q2 2020 Results - Earnings Call Transcript
11:14pm, Thursday, 23'rd Jul 2020
Edwards Lifesciences Corp. (NYSE:EW) Q2 2020 Earnings Conference Call July 23, 2020 5:00 PM ET Company Participants Mark Wilterding – Vice President-Investor Relations Mike Mussallem – Chairman an
